India’s apex drug regulator has allowed Pune-based Serum Institute of India to conduct late-stage — Phase 2 and 3 — human trials in India for the Oxford University Covid-19 vaccine candidate.
from Times of India https://ift.tt/39ZeN7J
from Times of India https://ift.tt/39ZeN7J
Serum gets DCGI nod for Phase 2 & 3 trials
![Serum gets DCGI nod for Phase 2 & 3 trials]()
Reviewed by GYM LOVER KATTA��
on
18:05
Rating:
No comments: